Page 341 - Read Online

Choi et al. Neuroimmunol Neuroinflammation 2018;5:42 I http://dx.doi.org/10.20517/2347-8659.2018.47 Page 13 of 14

controlling tissue-specific macrophage identities. Cell 2014;159:1327-40.
32. Goldmann T, Wieghofer P, Jordão MJ, Prutek F, Hagemeyer N, et al. Origin, fate and dynamics of macrophages at central nervous
system interfaces. Nat Immunol 2016;17:797-805.
33. Müller S, Kohanbash G, Liu SJ, Alvarado B, Carrera D, et al. Single-cell profiling of human gliomas reveals macrophage ontogeny as a
basis for regional differences in macrophage activation in the tumor microenvironment. Genome Biol 2017;18:234.
34. Venteicher AS, Tirosh I, Hebert C, Yizhak K, Neftel C, et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant
gliomas by single-cell RNA-seq. Science 2017; doi: 10.1126/science.aai8478.
35. Bowman RL, Klemm F, Akkari L, Pyonteck SM, Sevenich L, et al. Macrophage ontogeny underlies differences in tumor-specific
education in brain malignancies. Cell Rep 2016;17:2445-59.
36. Paolicelli RC, Ferretti MT. Function and dysfunction of microglia during brain development: consequences for synapses and neural
circuits. Front Synaptic Neurosci 2017;9:9.
37. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci
2007;10:1387-94.
38. Honda S, Sasaki Y, Ohsawa K, Imai Y, Nakamura Y, et al. Extracellular ATP or ADP induce chemotaxis of cultured microglia through
Gi/o-coupled P2Y receptors. J Neurosci 2001;21:1975-82.
39. Koizumi S, Fujishita K, Inoue K. Regulation of cell-to-cell communication mediated by astrocytic ATP in the CNS. Purinergic Signal
2005;1:211-7.
40. Cornejo F, von Bernhardi R. Age-dependent changes in the activation and regulation of microglia. Adv Exp Med Biol 2016;949:205-26.
41. London A, Cohen M, Schwartz M. Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert
in CNS plasticity and repair. Front Cell Neurosci 2013;7:34.
42. Mowat AM, Bain CC. Mucosal macrophages in intestinal homeostasis and inflammation. J Innate Immun 2011;3:550-64.
43. Shechter R, London A, Varol C, Raposo C, Cusimano M, et al. Infiltrating blood-derived macrophages are vital cells playing an anti-
inflammatory role in recovery from spinal cord injury in mice. PLoS Med 2009; doi: 10.1371/journal.pmed.1000113.
44. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000;164:6166-73.
45. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014;6:13.
46. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. The chemokine system in diverse forms of macrophage activation and
polarization. Trends Immunol 2004;25:677-86.
47. Orihuela R, McPherson CA, Harry GJ. Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 2016;173:649-65.
48. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 2005;23:344-6.
49. Sousa C, Biber K, Michelucci A. Cellular and molecular characterization of microglia: a unique immune cell population. Front Immunol
2017;8:198.
50. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol 2013;14:986-95.
51. Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, et al. Glioblastoma-infiltrated innate immune cells resemble M0
macrophage phenotype. JCI Insight 2016; doi: 10.1172/jci.insight.85841.
52. Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, et al. Differential roles of microglia and monocytes in the inflamed central
nervous system. J Exp Med 2014;211:1533-49.
53. Efthymiou AG, Goate AM. Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk. Mol Neurodegener
2017;12:43.
54. Morganti JM, Riparip LK, Rosi S. Call off the dog(ma): M1/M2 polarization is concurrent following traumatic brain injury. PLoS One
2016; doi: 10.1371/journal.pone.0148001.
55. Müller S, Kohanbash G, Liu SJ, Alvarado B, Carrera D, et al. Single-cell profiling of human gliomas reveals macrophage ontogeny as a
basis for regional differences in macrophage activation in the tumor microenvironment. Genome Biol 2017;18:234.
56. Italiani P, Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol 2014;5:514.
57. Wu SY, Watabe K. The roles of microglia/macrophages in tumor progression of brain cancer and metastatic disease. Front Biosci
(Landmark Ed) 2017;22:1805-29.
58. Annovazzi L, Mellai M, Bovio E, Mazzetti S, Pollo B, et al. Microglia immunophenotyping in gliomas. Oncol Lett 2018;15:998-1006.
59. Laudati E, Currò D, Navarra P, Lisi L. Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm.
Neurochem Int 2017;108:100-8.
60. Roesch S, Rapp C, Dettling S, Herold-Mende C. When immune cells turn bad-tumor-associated microglia/macrophages in glioma. Int J
Mol Sci 2018; doi: 10.3390/ijms19020436.
61. Li W, Graeber MB. The molecular profile of microglia under the influence of glioma. Neuro Oncol 2012;14:958-78.
62. da Fonseca AC, Amaral R, Garcia C, Geraldo LH, Matias D, et al. Microglia in cancer: for good or for bad? Adv Exp Med Biol
2016;949:245-61.
63. Hwang SY, Yoo BC, Jung JW, Oh ES, Hwang JS, et al. Induction of glioma apoptosis by microglia-secreted molecules: the role of nitric
oxide and cathepsin B. Biochim Biophys Acta 2009;1793:1656-68.
64. Kees T, Lohr J, Noack J, Mora R, Gdynia G, et al. Microglia isolated from patients with glioma gain antitumor activities on poly (I:C)
stimulation. Neuro Oncol 2012;14:64-78.
65. Garzon-Muvdi T, Theodros D, Luksik AS, Maxwell R, Kim E, et al. Dendritic cell activation enhances anti-PD-1 mediated
immunotherapy against glioblastoma. Oncotarget 2018;9:20681-97.
66. Weeratna RD, Makinen SR, McCluskie MJ, Davis HL. TLR agonists as vaccine adjuvants: comparison of CpG ODN and resiquimod
(R-848). Vaccine 2005;23:5263-70.
67. Carpentier A, Metellus P, Ursu R, Zohar S, Lafitte F, et al. Intracerebral administration of CpG oligonucleotide for patients with
recurrent glioblastoma: a phase II study. Neuro Oncol 2010;12:401-8.